Corporate & Commercial

Whether you are picking up a well-respected periodical or a celebrity news magazine, you cannot avoid reading about semaglutide injection drugs – drugs used to control blood sugar levels for individuals with type 2 diabetes and weight loss. “Ubiquitous” is the only word to describe the news coverage of these “miracle medications.” As news has

As most manufacturers know, employers employing 100 or more employees and federal contractors employing 50 or more employees meeting certain criteria are required to file component 1 data reports annually on the EEO-1 report with the U.S. Equal Employment Opportunity Commission (EEOC). The law requires covered employers to report on the racial/ethnic and gender composition

This week’s post is authored by Emilee Mooney Scott and is also available on Robinson+Cole’s Environmental Law + blog. Thank you to Emilee for contributing. Emilee is a partner in the firm’s Environmental, Energy + Telecommunications Group, focusing her practice on a variety of environmental compliance and transactional matters, including emerging contaminants.

As we have previously

This week’s post was co-authored by Edward Heath and Kevin Daly.  Attorneys Heath and Daly are members of Robinson+Cole’s Manufacturing Industry Team and regularly counsel clients on trade compliance, anti-corruption compliance, and other corporate compliance issues.

On September 26, 2023, U.S. export enforcement authorities, jointly with enforcement authorities in four allied countries (the Five